Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Gene expression of ERCC1 as a novel prognostic marker in advanced bladder cancer patients receiving cisplatin-based chemotherapy.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Gene expression of ERCC1 as a novel prognostic marker in advanced bladder cancer patients receiving cisplatin-based chemotherapy.
Gene expression of ERCC1 as a novel prognostic marker in advanced bladder cancer patients receiving cisplatin-based chemotherapy. Ann Oncol. 2007 Mar; 18(3):522-8.
View in:
PubMed
subject areas
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols
BRCA1 Protein
Caveolin 1
Cisplatin
Databases as Topic
Deoxycytidine
DNA-Binding Proteins
Endonucleases
Female
Follow-Up Studies
Gene Expression Regulation, Enzymologic
Gene Expression Regulation, Neoplastic
Humans
Kaplan-Meier Estimate
Male
Middle Aged
Paclitaxel
Prognosis
Proportional Hazards Models
Retrospective Studies
Ribonucleoside Diphosphate Reductase
RNA, Messenger
Time Factors
Treatment Outcome
Tumor Suppressor Proteins
Urinary Bladder Neoplasms
authors with profiles
Joaquin Bellmunt Molins, M.D.